OHSU Knight Cancer Institute, Beaverton is a clinical research site located in Beaverton, Oregon, United States 97006.
Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.
OHSU Knight Cancer Institute, Beaverton has participated in 2 clinical trials with 2 currently active.
Therapeutic areas: HER2-positive Breast Cancer, Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung.
Sponsors: Seagen, a wholly owned subsidiary of Pfizer.
Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
OHSU Knight Cancer Institute, Beaverton has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
OHSU Knight Cancer Institute, Beaverton has 2 clinical trials on record, with 2 currently active. Their work covers HER2-positive Breast Cancer, Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung.
OHSU Knight Cancer Institute, Beaverton has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.